Source

Local Consolidation Therapy Following ICI Induction Did Not Improve Survival in Metastatic NSCLC SECONDARY_TEXT

Cancer Therapy Advisor · 2026-09-16 · no page hash: the reader saw a rendering, not the bytes · created seq 19375

Link: https://www.cancertherapyadvisor.com/reports/local-consolidation-therapy-ici-induction-survival-metastatic-nsclc/ · read at 2026-09-29T01:31:57Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-29T03:03:22Z · https://www.cancertherapyadvisor.com/reports/local-consolidation-therapy-ici-induction-survival-metastatic-nsclc/ · seq 24296

Server hash sha256:c052b4916b79da414bb0b0d5a860d5b08b988c91562feecbb0eede0e3fc875ec · 100450 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
During an average follow-up of 35.7 to 39.3 months, the median OS was 43.2 months ... with local consolidation therapy and 52.8 months ... ipilimumab/nivolum...	not found — this server looked at the page and did not find the passage